BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 26423407)

  • 1. Risk of Cardiovascular Disease in an Aging HIV Population: Where Are We Now?
    Martin-Iguacel R; Llibre JM; Friis-Moller N
    Curr HIV/AIDS Rep; 2015 Dec; 12(4):375-87. PubMed ID: 26423407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol.
    Durand M; Chartrand-Lefebvre C; Baril JG; Trottier S; Trottier B; Harris M; Walmsley S; Conway B; Wong A; Routy JP; Kovacs C; MacPherson PA; Monteith KM; Mansour S; Thanassoulis G; Abrahamowicz M; Zhu Z; Tsoukas C; Ancuta P; Bernard N; Tremblay CL;
    BMC Infect Dis; 2017 Sep; 17(1):611. PubMed ID: 28893184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension Is a Key Feature of the Metabolic Syndrome in Subjects Aging with HIV.
    Martin-Iguacel R; Negredo E; Peck R; Friis-Møller N
    Curr Hypertens Rep; 2016 Jun; 18(6):46. PubMed ID: 27131801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Projecting 10-year, 20-year, and Lifetime Risks of Cardiovascular Disease in Persons Living With Human Immunodeficiency Virus in the United States.
    Losina E; Hyle EP; Borre ED; Linas BP; Sax PE; Weinstein MC; Rusu C; Ciaranello AL; Walensky RP; Freedberg KA
    Clin Infect Dis; 2017 Oct; 65(8):1266-1271. PubMed ID: 28605504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular health in an aging HIV population.
    Boccara F
    AIDS; 2017 Jun; 31 Suppl 2():S157-S163. PubMed ID: 28471946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular disease in HIV infection.
    Palella FJ; Phair JP
    Curr Opin HIV AIDS; 2011 Jul; 6(4):266-71. PubMed ID: 21546831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV infection, aging and cardiovascular disease: epidemiology and prevention.
    Petoumenos K; Worm SW
    Sex Health; 2011 Dec; 8(4):465-73. PubMed ID: 22127031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune activation and cardiovascular disease in chronic HIV infection.
    Longenecker CT; Sullivan C; Baker JV
    Curr Opin HIV AIDS; 2016 Mar; 11(2):216-25. PubMed ID: 26599166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of Cardiovascular Mortality for HIV-Infected Adults in the United States: 1999 to 2013.
    Feinstein MJ; Bahiru E; Achenbach C; Longenecker CT; Hsue P; So-Armah K; Freiberg MS; Lloyd-Jones DM
    Am J Cardiol; 2016 Jan; 117(2):214-20. PubMed ID: 26639041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease and HIV infection: host, virus, or drugs?
    Martínez E; Larrousse M; Gatell JM
    Curr Opin Infect Dis; 2009 Feb; 22(1):28-34. PubMed ID: 19532078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What happens to cardiovascular system behind the undetectable level of HIV viremia?
    d'Ettorre G; Ceccarelli G; Pavone P; Vittozzi P; De Girolamo G; Schietroma I; Serafino S; Giustini N; Vullo V
    AIDS Res Ther; 2016; 13():21. PubMed ID: 27127532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in overall and cause-specific mortality among HIV-infected adults on antiretroviral therapy in Europe, Canada and the US.
    Antiretroviral Therapy Cohort Collaboration (ART-CC)
    Antivir Ther; 2015; 20(1):21-8. PubMed ID: 24675571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular Disease Prevention Policy in Human Immunodeficiency Virus: Recommendations From a Modeling Study.
    Smit M; van Zoest RA; Nichols BE; Vaartjes I; Smit C; van der Valk M; van Sighem A; Wit FW; Hallett TB; Reiss P;
    Clin Infect Dis; 2018 Feb; 66(5):743-750. PubMed ID: 29029103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral molecules and cardiovascular diseases.
    Gibellini D; Borderi M; Clò A; Morini S; Miserocchi A; Bon I; Re MC
    New Microbiol; 2012 Oct; 35(4):359-75. PubMed ID: 23109004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular disease in human immunodeficiency virus.
    Cheruvu S; Holloway CJ
    Intern Med J; 2014 Apr; 44(4):315-24. PubMed ID: 24754684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular Disease in the Setting of Human Immunodeficiency Virus Infection.
    Pinto DSM; da Silva MJLV
    Curr Cardiol Rev; 2018 Mar; 14(1):25-41. PubMed ID: 29189172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of cardiovascular disease in HIV-infected patients.
    Das S
    J Antimicrob Chemother; 2010 Mar; 65(3):386-9. PubMed ID: 20026610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on cardiovascular complications in HIV infection.
    Currier JS
    Top HIV Med; 2009; 17(3):98-103. PubMed ID: 19675367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated cardiovascular disease and myocardial infarction risk in patients with the human immunodeficiency virus.
    Sharma TS; Messiah S; Fisher S; Miller TL; Lipshultz SE
    J Cardiometab Syndr; 2008; 3(2):93-7. PubMed ID: 18453809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise to Prevent Accelerated Vascular Aging in People Living With HIV.
    Jones R; Robinson AT; Beach LB; Lindsey ML; Kirabo A; Hinton A; Erlandson KM; Jenkins NDM
    Circ Res; 2024 May; 134(11):1607-1635. PubMed ID: 38781293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.